ALERIZON®
Oral solution, 0.5mg/ml
RxActive license
Active substance (INN)
desloratadine
Pharmaceutical form
Pharmaceutical formOral solution
Strength0.5mg/ml
PackagingUkupno 1 bočica staklena sa 60ml oralnog rastvora u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupRespiratory system (R06AX27)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJanuary 27, 2021
Analogs in Montenegro
6Other medicines with the same active substance
Source: CInMED register